[Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., Pinsky, M. R. (2001). Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med., 29(7), 1303-1310.10.1097/00003246-200107000-0000211445675]Search in Google Scholar
[Balding, J., Livingstone, W. J., Pittock, S. J., Mynett-Johnson, L., Ahern, T., Hodgson, A., Smith, O. P. (2004). The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension patients without a history of hypertension. Ir. J. Med. Sci., 173, 200-203.10.1007/BF0291455116323614]Search in Google Scholar
[Bennermo, M., Held, C., Stemme, S., Ericsson, C.-G., Silveira, A., Green, F., Tornvall, P. (2004). Genetic predisposition of the interleukin-6 response to inflammation: Implications for a variety of major diseases? Clin. Chem., 50(11), 2136-2140.]Search in Google Scholar
[Borden, E. C., Chin, P. (1994). Interleukin-6: A cytokine with potential diagnostic and therapeutic roles. J. Lab. Clin. Med., 123, 824-829.]Search in Google Scholar
[Casey, L. C., Balk, R. A., Bone, R. C. (1993). Plasma cytokine and endotoxin levels correlate with survival in patient with the septic syndrome. Ann. Intern. Med., 119, 771-778.10.7326/0003-4819-119-8-199310150-000018379598]Search in Google Scholar
[Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J. S., Humphries, S., Woo, P. (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemicv onset juvenile chronic arthritis. J. Clin. Invest., No. 102, 1369-1376.10.1172/JCI26295089849769329]Search in Google Scholar
[Flex, A., Gaetani, E., Pola, R., Santoliquido, A., Aloi, F., Papaleo, P. (2002). The 174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur. J. Vasc. Endovasc. Surg., 24, 264-268.10.1053/ejvs.2002.171112217290]Search in Google Scholar
[Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., Ramsay, G. (2003). 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitionsconference. Crit. Care Med., 31(4), 1250-1256.10.1097/01.CCM.0000050454.01978.3B12682500]Search in Google Scholar
[Schlüter, B., König, B., Bergmann, U., Müller, F. E., König, W. (1991). Interleukin 6—a potential mediator of lethal sepsis after major thermal trauma: Evidence for increased IL-6 production by peripheral blood mononuclear cells. J. Trauma, No. 31, 1663-1670.10.1097/00005373-199112000-000171749040]Search in Google Scholar
[Schlüter, B., Raufhake, C., Erren, M., Schotte, H., Kipp, F., Rust, S., Van Aken, H., Assmann, G., Berendes, E. (2002). Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit. Care Med., 32-37.10.1097/00003246-200201000-0000511902285]Search in Google Scholar
[Tischendorf, J. J. W. et al. (2007) The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int. J. Immunogen., 34(6) 413-418.10.1111/j.1744-313X.2007.00712.x18001296]Search in Google Scholar